Dr. Shah is the Founder and CEO of biopharmaceutical company Nirsum Laboratories L.L.C., a venture portfolio investment of Mountain Brook. Before founding Mountain Brook in 2013, Dr. Shah was a Portfolio Manager at Sigma Capital Management (a division of SAC Capital Management) and at HBK Capital Management. Earlier, Dr. Shah was a Managing Director at Great Point Partners and Analyst at Ursus Capital. Prior to his investment career, Dr. Shah was a practicing emergency physician, having completed a residency at the New York University/ Bellevue Hospital Center, where he focused on trauma and critical care. He holds an MD from the New York University School of Medicine and a BS in Biology from Cornell University.